NASDAQ
RKLB
Last Price
US $80.1
Valuation
Financial
Performance
Cash flow to debt coverage
Rocket Lab USA, Inc. cash flow to debt ratio of -65.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Rocket Lab USA, Inc.'s free cash flow has decreased 177.46% from $-115.98M last year to $-321.81M, signaling decreasing performance
Debt-to-equity ratio
Rocket Lab USA, Inc.'s debt to equity ratio is 0.04, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Rocket Lab USA, Inc.'s debt has decreased relative to shareholder equity from 1.22 last year to 0.04 today, signaling strengthened financials
Net debt to EBITDA
Rocket Lab USA, Inc. has a net cash position, so leverage is healthy.
Interest coverage
Rocket Lab USA, Inc.'s interest coverage ratio is -29.94, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Rocket Lab USA, Inc.'s profit margin has increased (-50.66%) in the last year from -43.60% to -21.51%, signaling increasing performance
Current ratio
Rocket Lab USA, Inc.'s short-term assets of $1.37B exceed its short-term liabilities of $334.48M
Return on assets
Rocket Lab USA, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Rocket Lab USA, Inc.'s return on equity of -7.56%, is lower than 15.00%, indicating bad performance
Earnings quality
Rocket Lab USA, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Rocket Lab USA, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Rocket Lab USA, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Rocket Lab USA, Inc. has negative free cash flow, indicating cash burn
Earnings growth
Rocket Lab USA, Inc.'s yearly earnings has decreased 4.22% since last year from $-190.18M to $-198.21M, signaling decreasing performance
Revenue growth
Rocket Lab USA, Inc.'s yearly revenue has increased 37.96% since last year from $436.21M to $601.80M, signaling increasing performance
Return on invested capital
ROIC -5.27% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Rocket Lab USA, Inc.'s 3-year revenue CAGR of 41.82% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Rocket Lab USA, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Rocket Lab USA, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Rocket Lab USA, Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Rocket Lab USA, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Rocket Lab USA, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Rocket Lab USA, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Rocket Lab USA, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Rocket Lab USA, Inc. has a price-to-book ratio of 14.43x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Price-to-sales ratio (TTM)
Rocket Lab USA, Inc. has a price-to-sales ratio of 65.53x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-7.56%
Return on equity
ROIC: -5.27%
Valuation History
-
Price to Earnings
EV/EBITDA: -363.3X
Cash flow
Profit margin
-21.75%
Cash flow
-30.32%
Fair Value
Market $80.1
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.